Interprotein Corporation Company Profile, Contacts & Intelligence

Biotechnology ResearchJp5 employees
1 contact with email or phone data1 with email data
View verified contacts Compare competitors
Employees
5
Company source estimate
Reachable Contacts
1
Visible contacts with email or phone data
Contacts With Email
1
1 of 3 visible contacts
Departments
1
Mapped contact coverage

Interprotein Corporation Overview

With twin platform technologies, Interprotein provides highly active modulators for protein-protein interaction (PPI) targets. Our proprietary technology (INTENDD®) is built upon a different conceptual foundation from MD-based docking simulation methods, generating highly active compounds with unique scaffolds. On the other hand, our newly constructed libraries of helix-loop-helix peptide achieved a near 100% success rate in identifying strong binders with KD values in low nanomolar range. INTENDD® With INTENDD®, we aim to develop and provide an in silico drug design platform specialized for producing small molecule PPI modulators, and extend this technology to establish an AI-based drug discovery program. Helix-loop-helix peptide Alternatively, we have developed extremely diverse libraries of helix-loop-helix peptides for phage-display screening. Phage-displayed random peptide screening enables us to achieve a near 100% success rate in identifying active peptides with high affinity and high specificity to PPI targets. In addition, we can easily modulate pharmacokinetic profiles via multiple approaches. Our promise Through collaborative R&D efforts, we will fully exploit our twin technologies for small molecules and peptides to identify highly active modulators against previously intractable PPI interfaces. We commit to turning current biologics (antibodies and soluble receptors)-based PPI inhibitions into more patient-friendly therapies with small molecule and/or peptide PPI modulators to change patients’ lives.

Headquarters
Jp
Website
interprotein.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Reaume Group

Interprotein Corporation Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

1 contact with contact data
1 with email data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
1 company-domain email
Visible contacts using Interprotein Corporation's company email domain.
Executive
1

Interprotein Corporation People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

H
Hirotsugu Komatsu
インタープロテイン - 取締役Cso兼事業開発本部長
T
Tim R. Kendall (ティム ケンダル)
Founder at Connektia. Bd&l Consultant
M
Masato Hosoda
CEO & President at Interprotein
E

Interprotein Corporation Workforce Composition

Seniority breakdown across 3 visible profiles.

Executive
2
Individual contributor
1

Compare Similar Companies to Interprotein Corporation

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
塩野義製薬（株） Pharmaceutical Manufacturing 187 View company
Panetta Physical Therapy Wellness And Fitness Services 40 View company
Kissei Pharmaceutical Co Ltd Multi-signal peer 34 View company
Luxna Biotech Co., Ltd. Biotechnology Research 9 View company
ダイドーグループホールディングス（株） Food And Beverage Manufacturing 7 View company
IMMUNOSENS Multi-signal peer 1 View company
Agripress - Prodotti Tipici Italiani Food And Beverage Services Not listed View company
PassPort Technologies, Inc. Pharmaceutical Manufacturing Not listed View company
Reaume Group, Inc. Manufacturing Not listed View company
Repertoire Genesis Inc. Biotechnology Research Not listed View company